In addition, they found that treatment with maximal medical management did not yield a significant improvement in mostquality-of-life metrics, with the cost/quality adjusted life-year (QALY) over the 2-year time-frame of $78,856 to $110,671, concluding thatthis strategy alone was not cost effective in thesepatient populations